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Introduction
HCV genome variability is related to both disease pro-
gression and treatment response. De novo high-through-
put pyrosequencing was used to obtain full length HCV
genome characterization directly from clinical samples.
Material and methods
Plasma samples from 3 HCV-infected subjects were ana-
lyzed (two patients with subtype 1b, one patient with sub-
type 2a/2c; viral load: 6.0x10
6,20.8x10
6 and 7.3x10
6 IU/ml
viral load, respectively). All samples were analyzed in a sin-
gle run, using sample-specific barcoding adapters. Data
were generated with a modified sequence-independent
single primer amplification followed by 454 sequencing
(GS-FLX Roche, Titanium version), using the shotgun
approach. The reads were assembled using cap3 program;
HCV contigs were identified using BLAST against full
HCV genome database. Reads of HCV contigs were used
for genome reconstruction with gs Mapper (Roche
software).
Results
A total of 297,493 reads were obtained (average length 267
bp). Using a minimum read length cut off of 40 nt with
>90% identity and >40% overlapping, BLAST analysis clas-
sified a total of 27,107 reads (10,682 from patient 1, 11,920
from patient 2, and 4,505 from patient 3) as HCV-specific.
In all patients, genome reconstruction was achieved for
more than 98 % of the entire HCV genome. The mean
coverage was 315, 307 and 142 reads per site for patients
1, 2 and 3, respectively (overall mean coverage: 253 reads
per site). Within-patient variability was calculated, result-
ing in E1 and E2 as the most variable structural genes in
all patients, as expected.
Conclusion
The present study describes a unifying approach for HCV
full genome sequencing, based on sequence-independent
amplification combined with next generation sequencing.
This may represent a relevant innovation, since so-far
HCV full genome direct sequencing was based on geno-
type-specific multiple primer approach and conventional
sequencing. The possibility of performing simultaneous
analysis of pooled samples may represent a further advan-
tage for cost saving.High coverage allows to analyze virus
v a r i a b i l i t ya l o n gt h ee n t i r eg e n o m ep r o v i d i n gi m p o r t a n t
information on possible viral variants which could impact
on clinical and therapeutic outcome.
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